Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Benign prostatic hyperplasia: antecedents and natural history.

× No keyword cloud information.

14 in total

1. The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men.

Authors: B Mozes; Y Maor; A Shmueli
Journal: Qual Life Res Date: 1999 Impact factor: 4.147

Review 2. Risk factors for benign prostatic hyperplasia.

Authors: Steven J Jacobsen
Journal: Curr Urol Rep Date: 2007-07 Impact factor: 3.092

3. Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.

Authors: C La Vecchia; F Levi; F Lucchini
Journal: J Epidemiol Community Health Date: 1995-08 Impact factor: 3.710

4. Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.

Authors: Jennifer L St Sauver; Michael M Lieber; Susan L Slager; Debra J Jacobson; Michaela E McGree; Steven J Jacobsen
Journal: BJU Int Date: 2011-04-11 Impact factor: 5.588

5. Inhibition of the CXCL12/CXCR4 axis prevents periurethral collagen accumulation and lower urinary tract dysfunction in vivo.

Authors: Jill A Macoska; Zunyi Wang; Johanna Virta; Nicholas Zacharias; Dale E Bjorling
Journal: Prostate Date: 2019-02-27 Impact factor: 4.104

6. Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.

Authors: Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; George G Klee; Michael M Lieber; Steven J Jacobsen
Journal: Am J Epidemiol Date: 2011-03-02 Impact factor: 4.897

Benign prostatic hyperplasia: antecedents and natural history.

1. The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men.

Review 2. Risk factors for benign prostatic hyperplasia.

3. Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.

4. Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.

5. Inhibition of the CXCL12/CXCR4 axis prevents periurethral collagen accumulation and lower urinary tract dysfunction in vivo.

6. Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.

7. Adherence to 5-alpha reductase inhibitor therapy for benign prostatic hyperplasia: clinical and economic outcomes.

8. Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model.

9. Longitudinal association between prostatitis and development of benign prostatic hyperplasia.

10. Effects of running distance and performance on incident benign prostatic hyperplasia.